Table 3. Stroke burden after adjustments.
| Variables | LAAO (n=30) | NOAC (n=86) | p value | ||
|---|---|---|---|---|---|
| Before adjustment | |||||
| mRS before the event | 0.3±0.2 | 0.6±0.1 | 0.22 | ||
| mRS at discharge | 1.8±0.3 | 2.7±0.2 | 0.03 | ||
| mRS at 3 months | 1.1±0.4 | 2.6±0.2 | <0.01 | ||
| mRS at 12 months | 1.0±0.4 | 2.5±0.2 | <0.01 | ||
| After adjustment | |||||
| Model 1* | |||||
| mRS at discharge | 1.8±0.3 | 2.7±0.2 | 0.03 | ||
| mRS at 3 months | 1.1±0.4 | 2.6±0.2 | <0.01 | ||
| mRS at 12 months | 1.0±0.4 | 2.5±0.2 | <0.01 | ||
| Model 2* | |||||
| mRS at discharge | 1.8±0.3 | 2.7±0.2 | 0.03 | ||
| mRS at 3 months | 1.1±0.4 | 2.6±0.2 | <0.01 | ||
| mRS at 12 months | 1.1±0.4 | 2.5±0.2 | <0.01 | ||
| Model 3* | |||||
| mRS at discharge | 1.9±0.3 | 2.6±0.2 | 0.07 | ||
| mRS at 3 months | 1.2±0.4 | 2.5±0.2 | <0.01 | ||
| mRS at 12 months | 1.1±0.4 | 2.5±0.2 | <0.01 | ||
Data are presented as the least square mean±standard error.
LAAO = left atrial appendage occlusion; mRS = modified Rankin Scale; NOAC = non-vitamin K antagonist oral anticoagulant.
*Model 1: adjusted for CHA2DS2-VASc score. Model 2: similar to model 1, with the additional inclusion of HAS-BLED score. Model 3: similar to model 2, with the additional inclusion of age, gender, and cardiovascular risk factors (age, sex, hypertension, diabetes mellitus, congestive heart failure and previous stroke/transient ischemic attack).